Výsledky vyhledávání - "Colnot, D. R."

Akademický článek

Bioactive glass (S53P4) as obliteration material in subtotal petrosectomy: initial experience.

Autor: Lindeboom, J J, Colnot, D R, Buwalda, J

Publikováno v: Journal of Laryngology & Otology; Jan2023, Vol. 137 Issue 1, p105-107, 3p

Zobrazit plný text záznamu

Superior semicircular canal dehiscencesyndroom en otosclerose

Autor: Van Hees, T. J., Quak, J. J., Naafs, D. B., Colnot, D. R.

Publikováno v: Nederlands Tijdschrift voor Keel-Neus-Oorheelkunde, 19(2), 57-60. Secretariaat KNO-vereniging

In this artide we describe an unusual presentation of conductive hearing loss caused by otosclerosis and superior semicircular canal dehiscence (SSCD) syndrome in one patiënt. SSCD typically presents with vertigo induced by loud sounds or by increas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::adfb8a0a8e4218e6fc8b20655218972d
https://research.vumc.nl/en/publications/334d5772-f636-47d6-b6d2-dd1493063376

Zobrazit plný text záznamu

Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy

Autor: Colnot, D. R., Wilhelm, A. J., Cloos, J., Roos, J. C., De Bree, R., Quak, J. J., Snow, G. B., Van Dongen, G. A M S

Publikováno v: Colnot, D R, Wilhelm, A J, Cloos, J, Roos, J C, De Bree, R, Quak, J J, Snow, G B & Van Dongen, G A M S 2001, ' Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy ', Journal of Nuclear Medicine, vol. 42, no. 9, pp. 1364-1367 .
Journal of Nuclear Medicine, 42(9), 1364-1367. Society of Nuclear Medicine Inc.

186Re-labeled chimeric monoclonal antibody U36 (cMAb U36) was recently evaluated in a phase I dose escalation study in head and neck cancer patients. All 13 patients received 99mTc-labeled cMAb U36 before 186Re-cMAb U36 radioimmunotherapy. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aefb2ae1975aef16f8a8935a69668183
https://research.vumc.nl/en/publications/1b13783c-54ab-498f-be94-1f0fda4226be

Zobrazit plný text záznamu

Phase I therapy study of 186re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck

Autor: Colnot, D. R., Jasper Quak, Roos, J. C., Lingen, A., Wilhelm, A. J., Kamp, G. J., Huijgens, P. C., Snow, G. B., Dongen, G. A. M. S.

Publikováno v: Colnot, D R, Quak, J J, Roos, J C, Van Lingen, A, Wilhelm, A J, Van Kamp, G J, Huijgens, P C, Snow, G B & Van Dongen, G A M S 2000, ' Phase I therapy study of 186 re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck ', Journal of Nuclear Medicine, vol. 41, no. 12, pp. 1999-2010 .
Scopus-Elsevier
Journal of Nuclear Medicine, 41(12), 1999-2010. Society of Nuclear Medicine Inc.

A phase I therapy study was conducted to determine the safety, maximum tolerated dose (MTD), pharmacokinetics, dosimetry, immunogenicity, and therapeutic potential of 186Re-labeled anti-CD44v6 chimeric monoclonal antibody (cMAb) U36 in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6f4d9970eadac90d15ce50c24fddeebe
https://research.vumc.nl/en/publications/419fc551-5b77-48ac-95a1-2a78f7e74d52

Zobrazit plný text záznamu

Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients

Autor: Nieuwenhuis, E. J., Colnot, D. R., Pijpers, H. J., Castelijns, J. A., van Diest, P. J., Brakenhoff, R. H., Snow, G. B., van den Brekel, M. W.

Publikováno v: Nieuwenhuis, E J, Colnot, D R, Pijpers, H J, Castelijns, J A, van Diest, P J, Brakenhoff, R H, Snow, G B & van den Brekel, M W 2000, ' Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients. ', Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, vol. 157, pp. 206-217 . https://doi.org/10.1007/978-3-642-57151-0_18
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, 157, 206-217. Springer New York
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 157, 206-217. Springer New York

Accurate staging of the regional lymph nodes is crucial for the appropriate management of patients with squamous cell carcinoma of the head and neck (HNSCC). However, the current diagnostic modalities have low accuracy for N0 neck, and even the most

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::512c2c44d83f86d9f3a20e298a63bad0
https://research.vumc.nl/en/publications/ffe01642-88fd-4126-adc7-e2b25e9c01ca

Zobrazit plný text záznamu

Molecular diagnosis of head and neck cancer

Autor: van Houten, V. M., van den Brekel, M. W., Denkers, F., Colnot, D. R., Westerga, J., van Diest, P. J., Snow, G. B., Brakenhoff, R. H.

Publikováno v: van Houten, V M, van den Brekel, M W, Denkers, F, Colnot, D R, Westerga, J, van Diest, P J, Snow, G B & Brakenhoff, R H 2000, ' Molecular diagnosis of head and neck cancer. ', Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, vol. 157, pp. 90-106 . https://doi.org/10.1007/978-3-642-57151-0_8

Patients with advanced stages of head and neck cancer frequently develop locoregional recurrence as well as distant metastases. These data indicate that traditional diagnostic methods such as histopathology and radiology are not sensitive enough to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::e3dbb9e65c12e590582e7534cb8ee0c9
https://research.vumc.nl/en/publications/c34ed694-7368-48f9-9782-cd4946f7f431

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Radioimmunotherapy with rhenium-186-labeled chimeric monoclonal antibody U36 in patients with head and neck squamous cell carcinoma

Autor: Colnot, D. R., Jasper Quak, Bree, R., Roos, J. C., Wilhelm, A. J., Snow, G. B., Dongen, G. A. M. S.

Publikováno v: Colnot, D R, Quak, J J, De Bree, R, Roos, J C, Wilhelm, A J, Snow, G B & Van Dongen, G A M S 1999, ' Radioimmunotherapy with rhenium-186-labeled chimeric monoclonal antibody U36 in patients with head and neck squamous cell carcinoma ', Acta oto-rhino-laryngologica belgica, vol. 53, no. 4 .
Scopus-Elsevier
Acta oto-rhino-laryngologica belgica, 53(4). Acta Medica Belgica

Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), the local failure rate and the incidence of distant metastases in these advanced stages is high. This might be due to remaining smal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::218572ae4627b0df9ce6a638e86025a4
https://research.vumc.nl/en/publications/79c68343-fce9-4cc7-b014-b24b49347d50

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání